Assia Bassarova

  • Consultant; MD, PhD
 

Publications 2019

Juraleviciute M, Pozniak J, Nsengimana J, Harland M, Randerson-Moor J, Wernhoff P, Bassarova A, Øy GF, Trøen G, Flørenes VA, Bishop DT, Herlyn M, Newton-Bishop J, Slipicevic A (2019)
MX 2 is a novel regulator of cell cycle in melanoma cells
Pigment Cell Melanoma Res, 33 (3), 446-457
DOI 10.1111/pcmr.12837, PubMed 31660681

Panagopoulos I, Gorunova L, Lund-Iversen M, Bassarova A, Heim S (2019)
Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma
Cancer Genomics Proteomics, 16 (5), 345-351
DOI 10.21873/cgp.20139, PubMed 31467228

Publications 2018

Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
J Am Acad Dermatol, 79 (1), 118-125.e1
DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861

Publications 2017

Panagopoulos I, Gorunova L, Spetalen S, Bassarova A, Beiske K, Micci F, Heim S (2017)
Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
Oncotarget, 8 (61), 103775-103784
DOI 10.18632/oncotarget.21790, PubMed 29262599

Publications 2015

Bassarova A, Troen G, Spetalen S, Micci F, Tierens A, Delabie J (2015)
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma in the Bone Marrow Paratrabecular Involvement as an Important Distinguishing Feature
Am. J. Clin. Pathol., 143 (6), 797-806
DOI 10.1309/AJCP6ZODWV1CIDME

Sedloev T, Bassarova A, Angelov K, Vasileva M, Asenov Y (2015)
Combination of Juvenile Papillomatosis, Juvenile Fibroadenoma and Intraductal Carcinoma of the Breast in a 15-Year-old Girl
Anticancer Res, 35 (9), 5027-9
PubMed 26254403

Publications 2013

Mantaka P, Helsing P, Gjersvik P, Bassarova A, Clausen OP, Delabie J (2013)
Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series
Acta Derm Venereol, 93 (3), 325-9
DOI 10.2340/00015555-1476, PubMed 23053197

Publications 2012

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-64
DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol Histopathol, 27 (10), 1315-25
DOI 10.14670/HH-27.1315, PubMed 22936450

Publications 2009

Bassarova A, Trøen G, Fosså A, Ikonomou IM, Beiske K, Nesland JM, Delabie J (2009)
Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
J Hematop, 2 (3), 135-41
DOI 10.1007/s12308-009-0031-2, PubMed 19669194

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
Histol Histopathol, 24 (8), 1049-59
DOI 10.14670/HH-24.1049, PubMed 19554512

Publications 2008

Bassarova A, Tierens A, Lauritzsen GF, Fosså A, Delabie J (2008)
Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?
Virchows Arch, 453 (4), 407-11
DOI 10.1007/s00428-008-0621-x, PubMed 18696109

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
Clin Cancer Res, 14 (8), 2341-50
DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823

Publications 2007

Paulsen T, Ree AH, Kaern J, Kjaerheim K, Bassarova A, Berner A, Haldorsen T, Tropé C, Nesland JM (2007)
Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation
Eur J Gynaecol Oncol, 28 (5), 356-63
PubMed 17966213

Publications 2006

Brandal P, Lie AK, Bassarova A, Svindland A, Risberg B, Danielsen H, Heim S (2006)
Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas
Mod. Pathol., 19 (2), 186-194
DOI 10.1038/modpathol.3800499

Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R (2006)
The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma
Gynecol Oncol, 102 (3), 453-61
DOI 10.1016/j.ygyno.2006.01.034, PubMed 16494928

Publications 2004

Bassarova A, Nesland JM, Sedloev T, Danielsen H, Christova S (2004)
Pilomatrix carcinoma with lymph node metastases
J Cutan Pathol, 31 (4), 330-5
DOI 10.1111/j.0303-6987.2004.0178.x, PubMed 15005691

Suo Z, Daehli KU, Lindboe CF, Borgen E, Bassarova A, Nesland JM (2004)
Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients
Int J Surg Pathol, 12 (4), 311-8
DOI 10.1177/106689690401200404, PubMed 15494857

Page visits: 41